Details

Last Funding Type

Seed

Last Funding Money Raised

£1.20M

Industries

Biotechnology,Health Care,Health Diagnostics,Machine Learning,Medical,Medical Device

Founded date

Jan 1, 2016

Number Of Employee

11 - 50

Operating Status

Active

It is our mission to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.

Dxcover are an award-winning team, dedicated to developing liquid biopsies for early detection of cancer and other diseases. A University of Strathclyde spinout in 2019 under the name ClinSpec Diagnostics, and rebranded as Dxcover Limited in 2021. To date, Dxcover have secured £5.1m of funding, and have successfully completed two ground-breaking clinical studies on detection of brain cancer and are currently developing our platform for the detection of commonly occurring cancers.